0000899243-20-010312.txt : 20200406 0000899243-20-010312.hdr.sgml : 20200406 20200406160609 ACCESSION NUMBER: 0000899243-20-010312 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200402 FILED AS OF DATE: 20200406 DATE AS OF CHANGE: 20200406 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIANAKAKOS ANASTASIOS CENTRAL INDEX KEY: 0001413822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37609 FILM NUMBER: 20777048 MAIL ADDRESS: STREET 1: 333 ALLERTON AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyoKardia, Inc. CENTRAL INDEX KEY: 0001552451 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455500552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SIERRA POINT PARKWAY CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-741-0900 MAIL ADDRESS: STREET 1: 1000 SIERRA POINT PARKWAY CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: MyoKardia Inc DATE OF NAME CHANGE: 20120618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-02 0 0001552451 MyoKardia, Inc. MYOK 0001413822 GIANAKAKOS ANASTASIOS C/O MYOKARDIA, INC. 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 1 1 0 0 President and CEO Common Stock 2020-04-02 4 S 0 600 43.5117 D 81196 D Common Stock 2020-04-02 4 S 0 1000 44.469 D 80196 D Common Stock 2020-04-02 4 S 0 300 45.35 D 79896 D Common Stock 2020-04-02 4 S 0 600 46.2267 D 79296 D Common Stock 225947 I By Reporting Person's Trust 2 Common Stock 323526 I By Reporting Person's Trust 3 Common Stock 12200 I By Trust 1 Common Stock 12200 I By Trust 2 Common Stock 12200 I By Trust 3 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Represents the weighted average sale price of the shares sold ranging from $42.91 to $43.89 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges reported in footnotes 2 through 5. Represents the weighted average sale price of the shares sold ranging from $43.99 to $44.97 per share. Represents the weighted average sale price of the shares sold ranging from $45.02 to $45.83 per share. Represents the weighted average sale price of the shares sold ranging from $46.03 to $46.54 per share. /s/Cynthia J. Ladd, as Attorney-in-Fact 2020-04-06